[SMC] Diagnostic dilemmas and challenges in the management of myasthenia in infants and toddlers: A case report

[RSS-Bot]

SAGE Open Med Case Rep. 2023 Nov 7;11:2050313X231211047. doi: 10.1177/2050313X231211047. eCollection 2023.

ABSTRACT

Myasthenia in the infancy and toddler age group is rare and often presents a challenge to treating pediatric neurologists. Our report addresses the challenges encountered when distinguishing myasthenia in infants and toddlers from similar illnesses, as well as the differentiation between congenital myasthenia, transient myasthenia, and autoimmune myasthenia. We present four cases of myasthenia between the ages of 10 and 30 months. The diagnosis and management of these cases were challenging due to the variability in clinical presentation. Four cases of myasthenia were diagnosed, with three having autoimmune myasthenia and one having congenital myasthenic syndrome. One patient initially tested negative for acetylcholine receptor antibodies, but later tested positive after 4 months and had a rare facial diplegia finding. The patient with congenital myasthenic syndrome had a novel genetic mutation, DPAGT1 homozygous variants, and also had false positive acetylcholine receptor antibodies. These cases highlight the importance of genetic testing for all infants and toddlers suspected of having myasthenia.

PMID:38022851 | PMC:PMC10631333 | DOI:10.1177/2050313X231211047


Source: https://pubmed.ncbi.nlm.nih.gov/3802285 ... t6+86293ac